'Bio-Treat trades at less than one third of its NAV and maybe four times earnings. That's what I call a giveaway valuation.'
-“Mr Shah- Shah Capital “
This ‘water-play’ has lot of value if not being play down by convertible bonds issue.
As there is news that BIO-TREAT Technology is in advanced discussions to get a bank loan to settle the convertible bondholders, the reversal may come home not too far now.
My personal accumulation will start when STI hit a new low in coming days.
0 comments
Post a Comment